From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

O Schmidt-Kittler, T Ragg… - Proceedings of the …, 2003 - National Acad Sciences
According to the present view, metastasis marks the end in a sequence of genomic changes
underlying the progression of an epithelial cell to a lethal cancer. Here, we aimed to find out …

[HTML][HTML] T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

A Rody, U Holtrich, L Pusztai, C Liedtke, R Gaetje… - Breast Cancer …, 2009 - Springer
Introduction Lymphocyte infiltration (LI) is often seen in breast cancer but its importance
remains controversial. A positive correlation of human epidermal growth factor receptor 2 …

[HTML][HTML] A clinically relevant gene signature in triple negative and basal-like breast cancer

A Rody, T Karn, C Liedtke, L Pusztai… - Breast cancer …, 2011 - Springer
Introduction Current prognostic gene expression profiles for breast cancer mainly reflect
proliferation status and are most useful in ER-positive cancers. Triple negative breast …

[HTML][HTML] Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures

T Karn, L Pusztai, U Holtrich, T Iwamoto, CY Shiang… - PloS one, 2011 - journals.plos.org
Background Current prognostic gene signatures for breast cancer mainly reflect proliferation
status and have limited value in triple-negative (TNBC) cancers. The identification of …

Identification of high risk breast-cancer patients by gene expression profiling

A Ahr, T Karn, C Solbach, T Seiter, K Strebhardt… - The Lancet, 2002 - thelancet.com
We previously used DNA array analyses in the molecular profiling of breast cancers. By
cluster analysis of 55 patients, we identified a subpopulation of breast cancers—designated …

Expression of p16 and lack of pRB in primary small cell lung cancer

J Yuan, J Knorr, M Altmannsberger… - The Journal of …, 1999 - Wiley Online Library
The retinoblastoma protein (pRB), p16, and cyclin D1 are major components of the RB
pathway, which controls the G1 checkpoint of the cell cycle. Proper regulation of this …

Molecular classification of breast cancer patients by gene expression profiling

A Ahr, U Holtrich, C Solbach, A Scharl… - The Journal of …, 2001 - Wiley Online Library
For many tumuors, pathological subclasses exist which have to be further defined by genetic
markers to improve therapy and follow‐up strategies. In this study, cDNA array analyses of …

Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of Plexin B1

A Rody, U Holtrich, R Gaetje, M Gehrmann… - Clinical cancer …, 2007 - AACR
Purpose: A common characteristic of mammary carcinomas is an inverse relationship
between the estrogen receptor (ER) status and the proliferative activity of the tumor. Yet, a …

Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer

T Karn, D Metzler, E Ruckhäberle, L Hanker… - Breast cancer research …, 2010 - Springer
Pooling of microarray datasets seems to be a reasonable approach to increase sample size
when a heterogeneous disease like breast cancer is concerned. Different methods for the …

[HTML][HTML] Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response …

T Karn, L Pusztai, E Ruckhäberle, C Liedtke… - European Journal of …, 2012 - Elsevier
BACKGROUND: Molecular markers displaying bimodal expression distribution can reveal
distinct disease subsets and may serve as prognostic or predictive markers or represent …